Furthermore, Kaplan-Meier, univariate and multivariate Cox analyses also disclosed the unfavorable impact of SRSF2 mutation on outcome in MDS patients with normal karyotype. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.